Could Peptide-Insulin Mixture Unlock the Prospect of Oral Diabetes Therapy?
Could Peptide-Insulin Mixture Unlock the Prospect of Oral Diabetes Therapy? April 28, 2021 The results of research by a team of scientists at Kumamoto University in Japan could feasibly provide the foundation for developing orally administered forms of insulin that would free diabetes patients from daily injections. The team’s studies first found that L-DNP peptide, a small intestine-permeable cyclic peptide originally used as an insulin additive to improve absorption into the small intestine, lowers blood glucose levels in mice. They then demonstrated that insulin can be administered orall...